The Case of an Itchy Scalp and Forehead Rash

Slideshow

Urticarial wet plaque, smaller pink urticarial lesions on the temple and eyelid, eyelid edema, no vesicles or pain. What's your diagnosis?

Urticarial lesions and eyelid edema, no vesicles or pain. Herpes simplex? Zoster? Viral exanthem? Contact dermatitis? Something else?

Recent Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
Related Content
US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose / image credit: ©New Africa/AdobeStock

US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose

Sydney Jennings
December 18th 2024
Article

Your daily dose of the clinical news you may have missed.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Approves Nemolizumab for Treatment of Moderate-to-Severe Atopic Dermatitis / Image credit: ©Argus/AdobeStock

FDA Approves Nemolizumab for Treatment of Moderate-to-Severe Atopic Dermatitis

Sydney Jennings
December 16th 2024
Article

Nemolizumab is the first approved monoclonal antibody that targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Sydney Jennings
September 13th 2021
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with incoming AAFP president Sterling Ransone, MD.

Upadacitinib Effective for Atopic Dermatitis in Adolescents at 76 Weeks: RCT Analysis / image credit: Amy S Paller, MS, MD Courtesy of Northwestern Medicine

Upadacitinib Safe and Effective for Atopic Dermatitis in Adolescents at 76 Weeks: RCT Analysis

Joshua Fitch
December 11th 2024
Article

Upadacitinib (15 and 30 mg) was evaluated in adolescents with moderate to severe AD aged 12 to 17 years, with and without topical corticosteroids.

Online UTI Myths Found Common, Dangerous: Daily Dose/ image credit: ©New Africa/AdobeStock

Online UTI Myths Found Common, Dangerous: Daily Dose

Sydney Jennings
December 10th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.